January 22, 2025 - 18:53

In a recent directive, acting health secretary Dorothy Fink has instructed federal health agencies to suspend most public communications until February 1. This memo, which has drawn significant attention, mandates that staff members must obtain explicit approval from a presidential appointee before engaging in any external dialogue regarding agency matters.
This move is seen as a significant shift in how health agencies interact with the public and media, raising concerns about transparency and communication during a critical time for public health. Employees are now faced with stringent limitations on sharing information, which could impact the dissemination of important health updates and guidance.
Critics argue that such restrictions could hinder the public's access to vital information, especially in the context of ongoing health challenges. As the agencies navigate this new communication landscape, the implications for public trust and engagement remain to be seen. The directive highlights the ongoing tension between governmental oversight and the need for open communication in public health.
March 10, 2026 - 02:49
Health care's exit backlog hits critical massThe long-anticipated wave of healthcare exits, from acquisitions to public offerings, has reached a critical juncture. While a significant backlog of companies awaiting liquidity events has built...
March 9, 2026 - 02:15
Mets Morning News: “He’s healthy, and we can see it now”A sense of optimism is buzzing through the New York Mets` camp following a standout spring training performance from a key pitcher. Team officials and coaches are openly expressing their enthusiasm...
March 8, 2026 - 16:48
**Des Moines Fitness Center Hosts Successful Fundraiser for Children's Health**A recent workout fundraiser at Life Time Des Moines channeled community energy into a powerful cause, generating significant support for children`s healthcare initiatives. The event directly...
March 7, 2026 - 20:04
Top FDA drug official is trying to hire a friend who’s seeking a warning about unproven side effects of antidepressantsA senior official at the U.S. Food and Drug Administration is attempting to hire a personal friend and researcher who is pushing the agency to place new warnings on antidepressant medications. The...